NDC 65841-804-30 - telmisartan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65841-804
- Requested NDC
- 65841-804-30
- Package NDCs from labels
- 65841-804-06, 65841-804-16, 65841-804-01, 65841-804-05, 65841-804-10, 65841-804-30, 65841-804-78
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-08-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| telmisartan - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-08-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65841-804-01 | telmisartan | 100 in 1 BOTTLE | TABLET | 100 | 8 | |
| 65841-804-05 | telmisartan | 500 in 1 BOTTLE | TABLET | 500 | 8 | |
| 65841-804-06 | telmisartan | 30 in 1 BOTTLE | TABLET | 30 | 8 | |
| 65841-804-10 | telmisartan | 1000 in 1 BOTTLE | TABLET | 1000 | 8 | |
| 65841-804-16 | telmisartan | 90 in 1 BOTTLE | TABLET | 90 | 8 | |
| 65841-804-30 | telmisartan | 1 in 1 BLISTER PACK | TABLET | 1 | 8 | |
| 65841-804-78 | telmisartan | 30 in 1 CARTON | TABLET | 30 | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TELMISARTAN | ACTIVE INGREDIENT | U5SYW473RQ | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| TELMISARTAN | ACTIVE MOIETY | U5SYW473RQ | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | TELMISARTAN TABLET [CADILA HEALTHCARE LIMITED] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Chain Drug Marketing Association Inc | 1a3f8819-58cf-8923-e063-6394a90a37af | 2025-11-06 | Warnings | 1K09F3G675 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS NO TOUCH SPRAY | Premier Brands of America Inc. | 36481d67-2346-470b-e063-6294a90aae99 | 2025-11-03 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | AmerisourceBergen Drug Corporation | f161e151-4fab-2fbc-e053-2a95a90a5437 | 2025-10-30 | Warnings | 1K09F3G675 |
| REMEDY Calazime Skin Protectant | CALAMINE, MENTHOL, WHITE PETROLATUM, ZINC OXIDE | Medline Industries, LP | 1295cfcc-5b61-481b-964b-f53ffd0cb58e | 2025-10-30 | Warnings | 1K09F3G675 |
| Calamine Plus | CALAMINE PLUS PRAMOXINE HCL | Meijer Distribution Inc. | 03c46823-0b1f-4101-e063-6294a90aaf94 | 2025-10-30 | Warnings | 1K09F3G675 |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 506T60A25R |
| Aveeno Anti-Itch Concentrated | ZINC OXIDE, FERRIC OXIDE RED, AND PRAMOXINE HYDROCHLORIDE | Kenvue Brands LLC | 07f4d4d0-9cee-46c3-bc71-2024abd31c9e | 2025-10-29 | Warnings | 1K09F3G675 |
| LACRIFRESH HYDRAPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41bbd23e-0ec8-eb18-e063-6294a90a46d1 | 2025-10-27 | Warnings | FZ989GH94E |
| LACRIFRESH HYDRAMAXPF | GLYCERIN, POVIDONE | AVIZOR, S.A. | 41be1604-89b4-7ec3-e063-6294a90a3331 | 2025-10-27 | Warnings | FZ989GH94E |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Premier Brands of America, Inc. | d3452573-f91f-f157-e053-2a95a90a1ad8 | 2025-10-27 | Warnings | 1K09F3G675 |
| Stye | POLYVINYL ALCOHOL AND POVIDONE | Medtech Products Inc. | 60c11d3d-df20-4d1c-b425-49a84fecea30 | 2025-10-23 | Warnings | FZ989GH94E |
| iVIZIA Dry Eye | POVIDONE | Thea Pharma Inc. | 1ef73cb1-da48-a713-e063-6294a90afa9d | 2025-10-20 | Warnings | FZ989GH94E |
| Telmisartan | TELMISARTAN | Preferred Pharmaceuticals Inc. | bf8e95fa-d181-4b46-8609-497e14a73dc1 | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | 205304 U5SYW473RQ |
| Telmisartan | TELMISARTAN | NuCare Pharmaceuticals, Inc. | 3f021f06-99df-48d1-e063-6394a90a8d0f | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | 205305 U5SYW473RQ |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 1K09F3G675 |
| telmisartan and hydrochlorothiazide | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Lifestar Pharma LLC | 0c1bd0f4-034e-486c-ae46-2855c8c9ebda | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | FSA Store Inc. | 3cd18f96-34f7-3f2c-e063-6294a90a3b7e | 2025-08-19 | Warnings | 1K09F3G675 |
| TELMISARTAN AND HYDROCHLOROTHIAZIDE | TELMISARTAN AND HYDROCHLOROTHIAZIDE | Solco Healthcare LLC | 47c8eee0-f0b7-4bd8-97e9-0029aa1b37db | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | U5SYW473RQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.